The group focuses on the very interface between bed-side clinical neurology and experimental models and rapid transport of basic ideas and application into preclinical testing.
The major targets include signaling mechanisms of inflammation and proteolytic vascular damage underlying thromboembolism as well as hemorrhage formation with and without thrombolytic therapy.
The main research lines:
Within these research lines we have established reproducible animal models in acute cerebral ischemia and hemorrhage and applied several imaging, tracing, histopathological and immunohistochemical techniques to monitor brain damage. We also utilize DNA-microarray technology to and have performed global genomic analyses from the human tissue materials.
We welcome new ambitious investigators (PhD or MD) with some experience in the above methodologies to join our group and excel in basic, yet clinically oriented neuroscience.